Evidence map›Paper›PMID 33844891›Full record

ArticleArchives of endocrinology and metabolism2021

Are clinicopathological features of the isthmic thyroid nodule different from nodules in thyroid lobes? A single center experience.

Fatma Dilek Dellal, Oya Topaloglu, Husniye Baser, Ahmet Dirikoc, Afra Alkan, Aysegul Aksoy Altinboga, Ibrahim Kilinc, Reyhan Ersoy, Bekir Cakir

Open access · diamondAbstract read
In one paragraph

Article in Archives of endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Do thyroid nodules in the isthmus carry a higher risk of malignancy? A systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fatma Dilek DellalAnkara City Hospital, Department of Endocrinology and Metabolism, Ankara, Turkey, drdellal@yahoo.com.
Oya TopalogluYildirim Beyazit University Medical Faculty, Department of Endocrinology and Metabolism, Ankara, Turkey.
Husniye BaserYildirim Beyazit University Medical Faculty, Department of Endocrinology and Metabolism, Ankara, Turkey.
Ahmet DirikocYildirim Beyazit University Medical Faculty, Department of Endocrinology and Metabolism, Ankara, Turkey.
Afra AlkanYildirim Beyazit University Medical Faculty, Department of Biostatistics, Ankara, Turkey.
Aysegul Aksoy AltinbogaYildirim Beyazit University Medical Faculty, Department of Pathology, Ankara, Turkey.
Ibrahim KilincAnkara City Hospital, Department of General Surgery, Ankara, Turkey.
Reyhan ErsoyYildirim Beyazit University Medical Faculty, Department of Endocrinology and Metabolism, Ankara, Turkey.
Bekir CakirYildirim Beyazit University Medical Faculty, Department of Endocrinology and Metabolism, Ankara, Turkey.
Ankara Yıldırım Beyazıt University · TRMemorial Ankara Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThyroid nodules located in isthmus were found less prevalent, although papillary thyroid cancer in this location was reported to be more aggressive behaviour in some studies. Our aim was to evaluate hormonal, ultrasonographic, and cytopathologic features of nodules located in isthmus (isthmic nodules).

methodsPatients who underwent thyroidectomy between 2006-2014 reviewed retrospectively. Hormonal, ultrasonographic, and cytopathologic features compared between patients with isthmic (Group-1) and with lober (non-isthmic, Group-2) nodules.

resultsGroup-1 and Group-2 consisted of 251 and 2076 patients, respectively. 260 isthmic (5.5%) and 4433 non-isthmic (94.5%) nodules were compared. However, most ultrasonographical features such as presence of microcalcification and halo, diameters, echogenicity, texture, margin, and vascularity were similar between groups, macrocalcification rate was lower in isthmic nodules (18.8%, 25.9%; p = 0.012). Cytologic results were also similar. Although malignancy rate was lower in isthmic nodules (6.2%, 12.5%; p = 0.002), type of thyroid cancer was similar in isthmic and non-isthmic nodules. When malignant isthmic (n = 16,2.8%) and malignant non-isthmic nodules (n = 553, 97.2%) were compared, diameter and type of tumor, lymphovascular and capsular invasions, extrathyroidal extension and multifocality rates were not statistically significant. Malignant isthmic nodules (n = 16, 6.2%) had smaller size [10.1 (7.5-34.5) mm, 19.95 (8.4-74.1) mm; p = 0.002], and higher hypoechogenicity rate (31.3%, 5.7%, p = 0.003) compared to benign isthmic nodules (n = 244, 93.8%). Negative predictive value was higher and positive predictive value was lower in isthmic nodules compared to non-isthmic nodules (p = 0.033, p = 0.047, respectively).

conclusionIsthmic nodules appear to be indolent because of having lower malignancy rate. FNAB might be required in isthmic nodules even if it has relatively small size. The surgery with limited extent or follow-up might seem to be reliable in the management of patients having isthmic nodules especially with indeterminate cytology.

Indexed as

Thyroid NeoplasmsThyroid NoduleHumansRetrospective StudiesThyroid Cancer, PapillaryUltrasonographycytologyhistopathologyIsthmusthyroid cancerultrasonography

Identifiers

PMID33844891
PMCPMC10065331
OpenAlexW3156652411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.